His scientific interests lie mostly in Hepatocellular carcinoma, Surgery, Internal medicine, Hepatectomy and Gastroenterology. His study in Hepatocellular carcinoma is interdisciplinary in nature, drawing from both Cirrhosis, Prospective cohort study, Carcinoma, Pathology and Radiology. Surgery is frequently linked to Liver function in his study.
In his study, which falls under the umbrella issue of Internal medicine, Chemotherapy is strongly linked to Oncology. His research integrates issues of Cancer, Metastasis, Preoperative care, Vascular disease and Bile duct in his study of Hepatectomy. The concepts of his Gastroenterology study are interwoven with issues in Hepatitis C virus, Adjuvant, Proportional hazards model, Adjuvant therapy and Hepatitis B virus.
Tadatoshi Takayama spends much of his time researching Internal medicine, Surgery, Hepatocellular carcinoma, Gastroenterology and Hepatectomy. Internal medicine and Oncology are frequently intertwined in his study. His Surgery study frequently draws parallels with other fields, such as Liver function.
His Hepatocellular carcinoma research includes elements of Survival rate, Carcinoma, Pathology, Cirrhosis and Radiology. His studies in Gastroenterology integrate themes in fields like Stage and Confidence interval. Hepatectomy is often connected to Vein in his work.
Tadatoshi Takayama mainly investigates Hepatocellular carcinoma, Internal medicine, Surgery, Gastroenterology and Radiology. His Hepatocellular carcinoma research incorporates themes from Confidence interval, Hazard ratio, Hepatectomy and Carcinoma. His work in Internal medicine addresses subjects such as Oncology, which are connected to disciplines such as Sorafenib.
The study of Surgery is intertwined with the study of Liver function in a number of ways. In his research on the topic of Gastroenterology, Survival rate is strongly related with Retrospective cohort study. His study focuses on the intersection of Cancer and fields such as Cancer research with connections in the field of Mutation, Methylation and DNA methylation.
His primary scientific interests are in Hepatocellular carcinoma, Internal medicine, Surgery, Gastroenterology and Hepatectomy. His Hepatocellular carcinoma study combines topics from a wide range of disciplines, such as Prospective cohort study, Carcinoma, Radiology and Radiofrequency ablation. His study in the fields of Hepatology, Sorafenib and Survival rate under the domain of Internal medicine overlaps with other disciplines such as Population.
His studies deal with areas such as Liver function and General surgery as well as Surgery. His work carried out in the field of Gastroenterology brings together such families of science as Stage, Hepatitis C, Retrospective cohort study and Hepatitis C virus. His biological study spans a wide range of topics, including Hemostasis, Cirrhosis, Malignancy and Blood loss.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma : a preliminary report
M Makuuchi;B L Thai;K Takayasu;T Takayama.
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
Hiroshi Imamura;Yutaka Matsuyama;Eiji Tanaka;Takao Ohkubo.
Journal of Hepatology (2003)
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial.
Tadatoshi Takayama;Teruaki Sekine;Masatoshi Makuuchi;Susumu Yamasaki.
The Lancet (2000)
One thousand fifty-six hepatectomies without mortality in 8 years.
Hiroshi Imamura;Yasuji Seyama;Norihiro Kokudo;Atsushi Maema.
Archives of Surgery (2003)
Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors.
Keiichi Kubota;Masatoshi Makuuchi;Koji Kusaka;Takashi Kobayashi.
Surgery for small liver cancers
Masatoshi Makuuchi;Tomoo Kosuge;Tadatoshi Takayama;Susumu Yamazaki.
Seminars in Surgical Oncology (1993)
Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results.
Masami Minagawa;Masatoshi Makuuchi;Guido Torzilli;Tadatoshi Takayama.
Annals of Surgery (2000)
Prognostic impact of anatomic resection for hepatocellular carcinoma.
Kiyoshi Hasegawa;Norihiro Kokudo;Hiroshi Imamura;Yutaka Matsuyama.
Annals of Surgery (2005)
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
Jordi Bruix;Tadatoshi Takayama;Vincenzo Mazzaferro;Gar Yang Chau.
Lancet Oncology (2015)
Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma.
T Takayama;T Kosuge;S Yamazaki;H Hasegawa.
The Lancet (1990)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: